Sarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program, for the 2022-2023 Academic Year
Source:
Nasdaq GlobeNewswire
/
07 Sep 2022 08:30:01 America/New_York
N/A
Share on,